Travel Vaccines Market 2026 expanding with global mobility trends
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Travel Vaccines Market Over The 2026–2030 Period?
The travel vaccines market has experienced substantial growth in recent years. This market is projected to expand from $5.09 billion in 2025 to $5.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. Historically, the growth can be attributed to several factors including limited access to vaccines in emerging markets, low public awareness of travel-related diseases, a continued reliance on traditional vaccination centers, regulatory approvals for mono vaccines, and the slow adoption of online booking platforms.
The travel vaccines market is projected to experience substantial expansion in the upcoming years, with its size forecast to reach $8.16 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. This anticipated growth can be attributed to increasing global travel and mobility, advancements in biotechnology for combination vaccines, the growth of digital health and telemedicine services, rising awareness of preventive healthcare, and the expansion of international travel immunization programs. Major trends influencing this period include a rise in international tourism and business travel, increasing awareness of preventive healthcare for travelers, the expansion of online travel health services and booking platforms, the development of combination and multivalent travel vaccines, and the growth in public-private partnerships for global immunization programs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp
What Underlying Factors Are Accelerating The Growth Of The Travel Vaccines Market?
The expanding domain of travel and tourism is anticipated to fuel the future expansion of the travel vaccine market. This sector encompasses the movement of individuals or objects, utilizing various modes of transport such as trains, boats, airplanes, and other conveyances, across different distant locations. Travel vaccines play a crucial role in safeguarding the health and well-being of tourists and travelers during their international journeys. As an illustration, UN Tourism, a Spain-based specialized agency dedicated to promoting responsible, sustainable, and universally accessible tourism, reported in May 2025 that over 300 million tourists undertook international travel within the first three months of 2025. This figure represents an increase of approximately 14 million compared to the corresponding period in 2024, signifying a 5% year-on-year rise. Consequently, the growing volume of travel and tourism activity is stimulating the expansion of the travel vaccine market.
How Is The Travel Vaccines Market Segmented Across Key Categories?
The travel vaccines market covered in this report is segmented –
1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel
Which Upcoming Trends Are Expected To Influence The Travel Vaccines Market?
Major companies in the travel vaccine market are developing advanced vaccines to offer active immunity and prevent Hepatitis A, a common concern for travelers. A travel vaccine is specifically designed to protect individuals from infectious diseases prevalent in certain areas or countries, often recommended for those visiting such regions. For instance, in January 2024, Indian Immunologicals Ltd. (IIL), an India-based biotechnology company, introduced Havisure, India’s first indigenously developed Hepatitis A vaccine. Havisure is expected to be vital in safeguarding against the Hepatitis A virus, which primarily affects the liver. This vaccine is effective in preventing the disease and is recommended for children as part of their routine immunization. Additionally, it is advised for individuals at risk of exposure or those traveling to areas with high rates of Hepatitis A.
Who Are The Dominant Players Shaping The Travel Vaccines Market Landscape?
Major companies operating in the travel vaccines market are Pfizer Inc, Johnson and Johnson, Merck & Co. Inc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Bharat Biotech International Limited, Bio Farma, Novavax Inc, Emergent BioSolutions UK, Biological E. Limited, Vabiotech, Cadila Healthcare Limited, Zydus Lifesciences Ltd, Cipla Inc, Haffkine Biopharmaceutical Corporation Ltd
Read the full travel vaccines market report here:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report
Which Region Is Projected To Dominate The Travel Vaccines Market During The Forecast Period?
North America was the largest region in the travel vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Travel Vaccines Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=11918&type=smp
Browse Through More Reports Similar to the Global Travel Vaccines Market 2026, By The Business Research Company
Travel Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Vaccine Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccine-delivery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
